PROACT Pilot Trial

Active, not recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

May 31, 2027

Conditions
Kidney Transplant Rejection
Interventions
DIAGNOSTIC_TEST

CXCL10 Monitoring at clinical frequency

The intervention is the implementation of real-time, serial urinary CXCL10 monitoring, with protocolized further clinical responses in the setting of elevated urinary CXCL10 levels.

Trial Locations (3)

V6H 3N1

BC Children's Hospital, Vancouver

R3E 3P4

The Children's Hospital of Winnipeg, Winnipeg

M5G 1E8

The Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

University of Toronto

OTHER

collaborator

University of Manitoba

OTHER

lead

University of British Columbia

OTHER

NCT06564649 - PROACT Pilot Trial | Biotech Hunter | Biotech Hunter